NO20020837D0 - Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer - Google Patents

Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer

Info

Publication number
NO20020837D0
NO20020837D0 NO20020837A NO20020837A NO20020837D0 NO 20020837 D0 NO20020837 D0 NO 20020837D0 NO 20020837 A NO20020837 A NO 20020837A NO 20020837 A NO20020837 A NO 20020837A NO 20020837 D0 NO20020837 D0 NO 20020837D0
Authority
NO
Norway
Prior art keywords
prostaglandin
receptor
receptors
identifying properties
substance
Prior art date
Application number
NO20020837A
Other languages
English (en)
Other versions
NO20020837L (no
Inventor
Hiroyuki Hirai
Kazuyuki Ogawa
Kinya Nagata
Syoichi Takano
Original Assignee
Bml Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bml Inc filed Critical Bml Inc
Publication of NO20020837D0 publication Critical patent/NO20020837D0/no
Publication of NO20020837L publication Critical patent/NO20020837L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20020837A 1999-08-23 2002-02-20 Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer NO20020837L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23620799 1999-08-23
JP2000153172 2000-05-24
PCT/JP2000/005615 WO2001014882A1 (fr) 1999-08-23 2000-08-22 Identification des proprietes d'une substance pour les recepteurs de prostaglandine d

Publications (2)

Publication Number Publication Date
NO20020837D0 true NO20020837D0 (no) 2002-02-20
NO20020837L NO20020837L (no) 2002-04-22

Family

ID=26532542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020837A NO20020837L (no) 1999-08-23 2002-02-20 Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer

Country Status (9)

Country Link
US (1) US6884593B1 (no)
EP (1) EP1211513B1 (no)
JP (1) JP3486408B2 (no)
AT (1) ATE315230T1 (no)
AU (1) AU772121B2 (no)
CA (1) CA2383135C (no)
DE (2) DE1211513T1 (no)
NO (1) NO20020837L (no)
WO (1) WO2001014882A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878522B2 (en) * 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2003030616A2 (en) * 2001-10-10 2003-04-17 Millennium Pharmaceuticals, Inc. 21132, a human g-protein coupled receptor family member and uses therefor
JP4484108B2 (ja) * 2002-05-16 2010-06-16 塩野義製薬株式会社 Ｐｇｄ２受容体拮抗作用を有する化合物
AU2003231513A1 (en) * 2002-05-16 2003-12-02 Shionogi And Co., Ltd. Pgd2 receptor antagonist
BR0317591A (pt) 2002-12-20 2005-11-22 Amgen Inc Composto, sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, métodos para tratar uma doença ou condição, para modular a função de crth2 e/ou um ou mais outros receptores de pgd2 em uma célula e para modular crth2 e/ou um ou mais outros receptores de pgd2
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
US7714132B2 (en) 2004-03-11 2010-05-11 Actelion Pharmaceuticals, Ltd. Tetrahydropyridoindole derivatives
CA2563707A1 (en) * 2004-04-20 2005-11-03 Pfizer Inc. Method of treating neuropathic pain using a crth2 receptor antagonsit
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
UY29223A1 (es) 2004-11-23 2006-06-30 Astrazeneca Ab Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
WO2007039736A1 (en) * 2005-10-06 2007-04-12 Astrazeneca Ab Novel compounds
AU2007279079A1 (en) 2006-07-22 2008-01-31 Oxagen Limited Compounds having CRTH2 antagonist activity
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
US20100280049A1 (en) * 2007-11-06 2010-11-04 Amira Pharmaceuticals, Inc. Antagonists of pgd2 receptors
WO2009061681A2 (en) * 2007-11-06 2009-05-14 Amira Pharmaceuticals, Inc Antagonists of pgd2 receptors
EA201001029A1 (ru) 2007-12-19 2011-06-30 Амген Инк. Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления
MY155133A (en) 2008-01-18 2015-09-15 Atopix Therapeutics Ltd Compounds having crth2 antagonist activity
US8168673B2 (en) 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
US20110098352A1 (en) * 2008-02-01 2011-04-28 Amira Pharmaceuticals, Inc. N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
AU2009210446C1 (en) 2008-02-01 2013-01-10 Brickell Biotech, Inc. N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
US8242145B2 (en) * 2008-02-14 2012-08-14 Panmira Pharmaceuticals, Llc Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
EP2245022A4 (en) * 2008-02-25 2012-02-22 Panmira Pharmaceuticals Llc ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
WO2009145989A2 (en) * 2008-04-02 2009-12-03 Amira Pharmaceuticals, Inc. Aminoalkylphenyl antagonists of prostaglandin d2 receptors
US20110190227A1 (en) * 2008-07-03 2011-08-04 Amira Pharmaceuticals, Inc. Antagonists of Prostaglandin D2 Receptors
GB2463788B (en) * 2008-09-29 2010-12-15 Amira Pharmaceuticals Inc Heteroaryl antagonists of prostaglandin D2 receptors
WO2010039977A2 (en) 2008-10-01 2010-04-08 Amira Pharmaceuticals, Inc. Heteroaryl antagonists of prostaglandin d2 receptors
WO2010042652A2 (en) 2008-10-08 2010-04-15 Amira Pharmaceuticals, Inc. Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
US20100173313A1 (en) * 2009-01-08 2010-07-08 Amira Pharmaceuticals, Inc. Biomarkers of inflammation
JP2013500978A (ja) 2009-07-31 2013-01-10 パンミラ ファーマシューティカルズ，エルエルシー． Ｄｐ２受容体アンタゴニストの眼の医薬組成物
SG10201404662YA (en) * 2009-08-05 2014-10-30 Panmira Pharmaceuticals Llc Dp2 antagonist and uses thereof
SG182398A1 (en) 2010-01-06 2012-08-30 Panmira Pharmaceuticals Llc Dp2 antagonist and uses thereof
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
CA3075688A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046677A1 (fr) * 1996-06-05 1997-12-11 Bml, Inc. PROTEINE SPECIFIQUE DU Th2 HUMAIN, GENE (B19) CODANT POUR CETTE PROTEINE, TRANSFORMANT, VECTEUR DE RECOMBINAISON ET ANTICORPS MONOCLONAL S'Y RAPPORTANT
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2

Also Published As

Publication number Publication date
WO2001014882A1 (fr) 2001-03-01
CA2383135C (en) 2010-11-30
DE1211513T1 (de) 2002-11-14
DE60025368D1 (de) 2006-03-30
CA2383135A1 (en) 2001-03-01
EP1211513B1 (en) 2006-01-04
US6884593B1 (en) 2005-04-26
AU6598800A (en) 2001-03-19
DE60025368T2 (de) 2006-09-14
JP3486408B2 (ja) 2004-01-13
NO20020837L (no) 2002-04-22
EP1211513A4 (en) 2003-04-16
EP1211513A1 (en) 2002-06-05
AU772121B2 (en) 2004-04-08
ATE315230T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
NO983431L (no) Anti-klöemidler
NO20010446L (no) Substituert anilidforbindelser og metoder
PT1333887E (pt) Metodo de tratamento de desordens musculares
BR9510486A (pt) Compostos moduladores de receptores de esteróide e métodos
DK1199069T3 (da) Anvendelse af en estrogenagonist/-antagonist til forbedring eller bibeholdelse af urogenital sundhed
AUPO755097A0 (en) Receptor agonist and antagonist
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DK0944731T3 (da) Enzymsensor
BR9710988A (pt) Método e compostos moduladores receptores de androgênio
BR0114054A (pt) Método para tratar alergias usando pirazóis substituìdos
TR199700956T1 (xx) Indazolkarboksamidler.
ES2162936T3 (es) Tratamiento de la ansiedad.
DK0730865T3 (da) Anvendelse af serotonin- og dopaminreceptor-blokkere til behandling af sindslidelser, som skyldes cerebrovasculær sygdom
DE60135130D1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE60138808D1 (de) G-protein gekoppelte rezeptoren
WO2003072558A3 (en) Arylsulfone derivatives
DE60033576D1 (de) Methoden zum screening knochenmorphogenetishemimetika
NO20062915L (no) Fremgangsmate til a identifisere modulatorer av aktiv KIT tyrosinkinase reseptor
NO20064354L (no) Fremgangsmate for bestemmelse av sympatisk tonus og system for maling derav
MXPA04010915A (es) Base y procedimiento de conocimiento de recursos humanos dinamicos.
PT1165595E (pt) Derivados de acidos biliares especificos do figado provenientes do antagonista do glicocorticoide ru486
TR199701613T1 (xx) Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri.
NO20033401D0 (no) Kjemiske forbindelser